Dr Kesinee Chotivanich
More effective diagnosis and treatments are needed to reduce the morbidity and mortality affecting malaria patients. Researchers at the Malaria Laboratory at MORU study the pathophysiology of the disease, and test new compound drugs for anti-malarial activity. In the context of growing artemisinin resistance, this research will have a global impact
The MORU Malaria laboratory, Bangkok, Thailand provides facilities and resources to researchers, students, and collaborators who are interested in tropical diseases. We aim to generate new knowledge in order to improve patients’ care. Major research areas of interest are the pathophysiology of malaria, host-parasite interaction, the pharmacodynamics of antimalarial drugs, the mechanism of antimalarial drug resistance, and the development diagnostic tools. Currently, we have 5 PhD students and 9 scientists working in our laboratory.
Witmer K. et al, (2020), Antimicrobial agents and chemotherapy, 65
Brummaier T. et al, (2020), Malaria Journal, 19
Imad HA. et al, (2020), The American journal of tropical medicine and hygiene, 102, 943 - 950
van der Pluijm RW. et al, (2020), The Lancet, 395, 1345 - 1360
Witmer K. et al, (2020)